This article appeared in the March 2015 ASX Investor Update email newsletter. To subscribe to this newsletter please register with the MyASX section or visit the About MyASX page for past editions and more details.
Here is a snapshot of entities that had applied for admission to the official list of ASX, as at March 4, 2015. Upcoming floats has more information, and Recent floats and listings provides information on entities that have listed on ASX in the previous two months. Note: information about upcoming floats can change quickly if companies close their IPO ahead of schedule, or decide to extend their offer. Check the ASX website or talk to your financial adviser for latest information. IPO listing and closing dates are indicative only.
Aeeris provides early-warning alerts and forecasting services to individuals, small business, large business and corporations across Australia and internationally. Capital to be raised: Up to $6 million.
ALT Resources is an Australian based mineral exploration company incorporated in April 2014 to acquire up to a 70 per cent interest in tenements held by GFM Exploration (GFM). GFM is the registered holder of three tenements in the south-east Lachlan Orogen in New South Wales. Capital to be raised: $4 million.
Genetic Signatures has developed and commercialised a suite of EasyScreen™ Real-Time PCR based kits for the routine detection of infectious diseases. The EasyScreen™ kits provide hospital and pathology laboratories with the molecular tools to screen for a wide array of infectious pathogens in a rapid and high-throughput environment. Capital to be raised: $15 million.
iQ3 is the world's first specialised life science corporate financial advisory and asset management firm. It provides advice to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments, and individuals. Capital to be raised: $4.4 million.
Proteomics International Laboratories is an innovative biological research and drug discovery company working to make a difference in people's lives by developing simple diagnostic tests for common diseases and discovering new therapeutic drugs. Capital to be raised: $15 million.
A long-established skydiving company with 11 existing drop zones across Australia. Skydive is in the process of acquiring another five drop zones on Australia's East Coast. Capital to be raised: $20 million.
The entities listed above have made application for admission to the official list of ASX. Part of this application process includes the allocation of a provisional ASX code and the provision of details about the entity on the linked page below. In some instances ASX provides a link to a third-party site from which the offer document and application form may also be available for download.
The allocation of a code and the provision of a link to a third-party site does not in any way imply that the entity's application for admission to the official list will be approved and should not be considered in any way as an indication of the merits of the entity. Use of a link to a third-party site indicates your acceptance of the conditions.
It is advisable to obtain investment advice before making any investment decisions relying on information provided on a third-party site, and the entity's offer document should be read in its entirety before any decision is made to invest in the entity's securities.
© Copyright 2017 ASX Limited ABN 98 008 624 691. All rights reserved 2017.